Theravance Biopharma, Inc. (TBPH)
NASDAQ: TBPH · Real-Time Price · USD
11.41
-0.05 (-0.44%)
Jul 11, 2025, 9:30 AM - Market open

Theravance Biopharma Market Cap

Theravance Biopharma has a market cap or net worth of $570.52 million as of July 11, 2025. Its market cap has increased by 33.77% in one year.

Market Cap
570.52M
Enterprise Value
490.32M
1-Year Change
33.77%
Ranking
Category
Stock Price
$11.41

Market Cap Chart

Since May 16, 2014, Theravance Biopharma's market cap has decreased from $740.70M to $570.52M, a decrease of -22.98%. That is a compound annual growth rate of -2.31%.

History

DateMarket Cap% Change
Jul 10, 2025 573.00M 23.84%
Dec 31, 2024 462.70M -17.33%
Dec 29, 2023 559.70M -25.95%
Dec 30, 2022 755.80M -7.20%
Dec 31, 2021 814.40M -28.37%
Dec 31, 2020 1.14B -22.64%
Dec 31, 2019 1.47B 3.64%
Dec 31, 2018 1.42B -6.02%
Dec 29, 2017 1.51B -8.88%
Dec 30, 2016 1.66B 166.99%
Dec 31, 2015 620.20M 28.99%
Dec 31, 2014 480.80M -35.09%
View and export this data all the way back to 2014. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Eli Lilly and Company 706.45B
Johnson & Johnson 376.02B
AbbVie 336.71B
Novo Nordisk 308.58B
UnitedHealth Group 274.78B
Novartis AG 240.09B
Abbott Laboratories 231.78B
AstraZeneca 218.25B
Market Cap Rankings